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Abstract Regulation of cell wall assembly is essential for bacterial survival and contributes to
pathogenesis and antibiotic tolerance in Mycobacterium tuberculosis (Mtb). However, little is
known about how the cell wall is regulated in stress. We found that CwlM, a protein homologous to
peptidoglycan amidases, coordinates peptidoglycan synthesis with nutrient availability.
Surprisingly, CwlM is sequestered from peptidoglycan (PG) by localization in the cytoplasm, and its
enzymatic function is not essential. Rather, CwlM is phosphorylated and associates with MurA, the
first enzyme in PG precursor synthesis. Phosphorylated CwlM activates MurA ~30 fold. CwlM is
dephosphorylated in starvation, resulting in lower MurA activity, decreased cell wall metabolism,
and increased tolerance to multiple antibiotics. A phylogenetic analysis of cwlM implies that
localization in the cytoplasm drove the evolution of this factor. We describe a system that controls
cell wall metabolism in response to starvation, and show that this regulation contributes to
antibiotic tolerance.
DOI: 10.7554/eLife.14590.001
Introduction
Mycobacterium tuberculosis (Mtb), a bacterium that causes 1.5 million deaths a year (Sharma et al.,
2006; World Health Organization, 2014), differs from many bacterial pathogens in its infection
strategy, which depends on an unusual cell envelope (Cambier et al., 2014). The importance of this
structure is evident from the fact that at least a quarter of the genes in the Mtb genome are involved
in its construction and regulation (Doerks et al., 2012). The mycobacterial cell wall consists of pepti-
doglycan (PG) covalently bound to a layer of arabinogalactan sugars, which is in turn covalently
bound to a layer of mycolic acid lipids that make up an outer membrane (Alderwick et al., 2015;
Cambier et al., 2014).
While the chemistry of this cell envelope is increasingly well defined, its regulation is poorly
understood. Regulated cell wall changes are essential for Mtb to cause disease (Doerks et al., 2012;
Sharma et al., 2006) and are thought to contribute to phenotypic antibiotic tolerance. TB therapy
requires 6–12 months of drug treatment. This is likely due, in part, to drug tolerance like that
observed in stressed, non-growing Mtb cultures (Wallis et al., 1999). Because stressed Mtb also
exhibits cell wall changes such as thickening, differential staining and chemical alterations
(Bhamidi et al., 2012; Cunningham and Spreadbury, 1998; Seiler et al., 2003), it seems probable
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that the cell wall changes contribute to antibiotic tolerance. Importantly, starved, antibiotic tolerant
Mtb cells have been shown to be less permeable to antibiotics (Sarathy et al., 2013). However, the
regulatory mechanisms that induce cell wall changes in response to stress and contribute to imper-
meability and tolerance have not been described.
The peptidoglycan (PG) layer provides protection and shape-defining structure to cells of almost
all bacterial species. This layer is constructed by transpeptidases and glycosyltransferases, which
attach new precursors to the existing cell wall; and several types of catabolic PG hydrolases, which
break bonds in the existing PG. PG enzymes must be tightly regulated to promote cell growth and
septation without compromising the wall integrity, and to restructure the cell wall to withstand
stresses (Kieser and Rubin, 2014). Accordingly, a large number of regulators in the cytoplasm, inner
membrane and periplasm coordinate and control the activities of the PG enzymes, either directly or
indirectly (Kieser and Rubin, 2014; Typas et al., 2011).
In addition to the dedicated regulators, many PG synthases and hydrolases work together in com-
plexes and regulate each others’ enzymatic activity through protein-protein interactions
(Banzhaf et al., 2012; Hett et al., 2010; Smith and Foster, 1995). Notably, some PG hydrolases
have lost their enzymatic activity and function only as regulators: EnvC in E. coli is missing catalytic
residues from its active site but contributes to cell septation by activating the PG amidases AmiA
and AmiB (Uehara et al., 2010; Yang et al., 2011).
In this work we study the predicted PG hydrolase, CwlM, and find that its essential function is reg-
ulatory rather than enzymatic. We find that CwlM is located in the cytoplasm, is phosphorylated by
the essential Serine Threonine Protein Kinase (STPK) PknB, and functions to stimulate the catalytic
activity of MurA, the first enzyme in the PG precursor synthesis pathway. In nutrient-replete condi-
tions CwlM is phosphorylated. Using in vitro biochemistry we show that phosphorylated CwlM
(CwlM~P) increases the rate of MurA catalysis by ~30 fold. In starvation, CwlM is dephosphorylated
and in this state does not activate MurA, which has very low activity alone (Xu et al., 2014). Impor-
tantly, we find that over-activation of MurA in the transition to starvation causes increased sensitivity
to multiple classes of antibiotics. Finally, a phylogenetic analysis implies that CwlM protein evolution
was driven by localization to the cytoplasm.
eLife digest Bacterial cells are surrounded by a protective cell wall. Some bacteria, including
the species Mycobacterium tuberculosis that causes tuberculosis, have the ability to change the
properties of their cell wall when exposed to stressful conditions. These changes may also help the
bacteria to resist the antibiotics used to treat the infections they cause. However, little is known
about how changes to the cell wall are regulated.
By carrying out genetic experiments in a non-infectious relative of M. tuberculosis and by
performing biochemical assays with M. tuberculosis proteins, Boutte et al. have now investigated the
role of a bacterial protein called CwIM. This protein was predicted to be an enzyme that cuts
peptidoglycan, a network of sugars and short proteins that forms part of the bacterial cell wall. Such
an enzyme would allow the peptidoglycan to expand and remodel. However, Boutte et al. found
that CwlM does not act as an enzyme. Instead, it regulates an enzyme called MurA, which is present
inside bacteria and helps to make the peptidoglycan network. Thus, CwIM actually helps to
determine how much peptidoglycan a cell produces.
When activated, the CwlM protein binds to MurA and stimulates it to start producing
peptidoglycans. However, Boutte et al. observed that CwlM is active only when cells have plenty of
nutrients. When nutrients are scarce, CwlM deactivates and reduces the activity of the MurA
enzyme. This quickly shuts down the production of peptidoglycan and makes starved cells tolerant
to antibiotics. Notably, increasing peptidoglycan production in starved cells, by enhancing the
activity of the MurA enzyme, makes the cells more vulnerable to several antibiotics.
Future work could now investigate the conditions under which CwlM is activated and deactivated
in M. tuberculosis during an infection. It also remains to be seen whether other enzymes are
regulated in a similar way to MurA.
DOI: 10.7554/eLife.14590.002
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Results
cwlM (Rv3915, MSMEG_6935) is predicted to be essential for growth in Mtb (Zhang et al., 2012), is
highly conserved among mycobacteria, and is annotated as an N-acetylmuramoyl-L-alanine amidase
of the AmiA/LytC family (hereafter: PG amidase), a type of PG hydrolase. CwlMTB has been shown
to have PG amidase activity (Deng et al., 2005); however, key residues that coordinate the catalytic
Zn2+ are not conserved in CwlM from both Mtb and Msmeg (Yamane et al., 2001) (Figure 1A),
implying that it is inefficient as an enzyme. This is supported by our observation that overexpression
of CwlM did not affect cell viability (Figure 1—figure supplement 1): overexpression of highly active
PG hydrolases usually results in cell lysis (Uehara and Bernhardt, 2011). Thus, we hypothesized that
CwlM’s essential function might not be enzymatic. Certain PG hydrolases in E. coli function as regu-
lators of other PG hydrolases rather than as enzymes (Uehara et al., 2010). We hypothesized that
CwlM may have a similar role in activating an essential enzyme.
CwlM is essential for growth in M. smegmatis, but may have a non-
enzymatic function
To confirm the essentiality of cwlM in Msmeg we constructed a strain (See Supplementary file 1 for
full descriptions of all strains), Ptet::cwlM, in which the only copy of cwlM is under control of an anhy-
drotetracyline (Atc)-inducible promoter. Depletion of CwlM by removing Atc results in cell death
(Figure 1B). Microscopy of CwlM-depleted cells shows that they are short, implying a defect in elon-
gation. To assess polar elongation (Aldridge et al., 2012; Thanky et al., 2007), we stained cells
with an amine reactive dye (ARD) (Aldridge et al., 2012) and cultured them to allow new, unstained
polar cell wall to form before imaging (Figure 1C). We found that CwlM-depleted cells fail to elon-
gate normally (Figure 1D,E,F).
To determine if CwlM requires amidase activity for its essential function, we mutated the active
site aspartate and glutamate that coordinate the catalytic Zn2+ (Prigozhin et al., 2013) and have
been shown to be required for catalysis in related proteins (Prigozhin et al., 2013; Shida, 2001).
We performed allele swapping at the L5 phage integrase site (Pashley and Parish, 2003) to replace
the wild-type (WT) cwlM with the mutant allele cwlM E209A D331A. cwlM E209A D331A has zero
out of four conserved Zn2+-coordinating residues, but is able to complement the WT allele in a
growth curve assay (Figure 1G). Thus, CwlM is essential for cell survival and elongation in Msmeg,
but its presumed amidase active site does not appear to be essential. CwlM may therefore have
another function.
CwlM is phosphorylated, and this phosphorylation is important for cell
growth
A proteomic screen in Mtb found that CwlMTB is phosphorylated at T43 and T382 (Prisic et al.,
2010). To determine whether the Msmeg CwlM is also phosphorylated, we constructed a strain with
an epitope-tagged allele (cwlM::FLAG), immunoprecipitated the protein from Msmeg lysate and
separated it with 2D gel electrophoresis. We found several CwlM species with different isoelectric
points, a hallmark of phosphorylation (Figure 2A). Mass spectrometry of the gel spots identified
phosphorylation at T35 and T374 (equivalent to T43 and T382 in the Mtb protein), as well as T376
and T378, and acetylation at K362 and K369. Most of the modifications are found at the C-terminal
tail of the protein, which is highly conserved across actinomycetes (Figure 2B), despite being outside
of a conserved domain. To assess whether phosphorylation is important for function, we replaced
WT cwlM at the L5 site with mutants in which phosphorylated threonine residues were replaced by
alanines. Most mutants grew normally but the L5::cwlM T374A strain grew slowly (Figure 2C; Fig-
ure 2—figure supplement 1A), despite containing normal amounts of CwlM protein (Figure 2D).
The L5::cwlM T374A cells were short (Figure 2E) and defective for polar elongation (Figure 2F).
Because the phenotypes of the L5::cwlM T374A strain are similar to the CwlM depletion (Figure 1),
it seems likely that absence of phosphorylation on T374 inhibits the essential function of CwlM,
though the T374A mutation could interrupt CwlM function in another way.
Peptidoglycan hydrolases and their direct regulators are found in the periplasm; however, CwlM
lacks classical sec or tat secretion signal sequences (Bagos et al., 2010; Petersen et al., 2011).
Moreover, phosphorylation of periplasmic proteins has not been described. To determine the com-
partmental location of CwlM, we used the Substituted Cysteine Accessibility Method (SCAM)
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(Karlin and Akabas, 1998). We measured the accessibility of a cysteine on CwlM to agents with dif-
ferent membrane permeability and found that CwlM is only accessible to agents that can reach the
cytoplasm (Figure 2G). Thus, CwlM is a cytoplasmic protein whose essential function is likely acti-
vated by phosphorylation.
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Figure 1. CwlM’s essential function promotes polar growth, but not through enzymatic activity. (A) Alignment of the active-site proximal regions of the
enzymatic domain of PG amidases. The Zn2+-coordinating residues are boxed: the conserved aspartate/ glutamates in green, and the degenerate
histidine/ arginines in red. (B) Colony forming units (CFU) of the Ptet::cwlM (CB82) strain grown with (+CwlM) or without ( CwlM) Atc inducer from Time
0. Data from all experiments throughout is from three biological replicates and error bars are the standard deviation, unless otherwise noted. (C)
Cartoon of the amine reactive dye (ARD) staining method showing polar growth after staining, with a diagram of how cell length and polar growth were
measured for Figures 1EF and 2EF. (D) Overlaid micrographs of the Ptet::cwlM strain grown with (+CwlM) or without ( CwlM) Atc for 9 hr, stained with
ARD, grown 3 hr and imaged with a 488/530 filter (green) and in phase (red and black). Representative cells from several images used in E and F were
pasted together, the scale is conserved between images. (E) The length of ~230 cells from each condition in (D). Two biological replicates were used
for all microscopy experiments, unless noted. (F) The length of the longer unstained pole of the cells in (E), line indicates the median in (E) and (F). ****
p value <0.0001. (G) Growth curves showing the OD660 of WT (L5::cwlM, CB236) and amidase-ablated (L5::cwlM D209A E331A, CB239) strains growing
in 7H9, and a bar graph showing the calculated doubling times of these strains (inset). n.s. – not significant. The p value was 0.51 by the student’s t-test
DOI: 10.7554/eLife.14590.003
The following figure supplement is available for figure 1:
Figure supplement 1. Overexpression of CwlM.
DOI: 10.7554/eLife.14590.004
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Figure 2. CwlM is phosphorylated and cytoplasmic. (A) 2-D gel of CwlM-FLAG from Msmeg (CB100) with the
isoelectric point (pI) indicated on the bottom. (B) Weblogo diagrams of the C-terminus of CwlM homologues.
Acetylation (Ac) and phosphorylation (PO4) sites are indicated. The colors of the three phosphates match the
colors of the corresponding phospho-ablative strains in C, E and F. (C) Doubling times of L5::cwlM-FLAG WT
(CB300) and phospho-ablative mutants (T374A = CB300; T376A = CB345; T378A = CB348). All multiple
comparisons throughout were performed by One-way ANOVA with a Dunnett multiplicity correction. The adjusted
p values for each mutant compared to WT are: T374A =< 0.0001; T376A = 0.88; T378A = 0.15. (D) a-strep western
blot of L5::cwlM-strep WT (CB663) and phospho-ablative mutants (CB666, 669, 672). A background band on the
same blot probed with a-FLAG is used as a control. Westerns of the L5::cwlM-FLAG strains could not be used
because of high background. (E) Cell length of 200–300 cells from L5::cwlM-FLAG WT and phospho-ablative
mutants. The adjusted p values for each mutant compared to WT are: T374A =< 0.0001; T376A = 0.99;
T378A = 0.01. (F) Length of the longer unstained pole of cells in (E). Cells were stained with ARD and grown for
three hours before imaging. The adjusted p values for each mutant compared to WT are: T374A =< 0.0001;
T376A = 0.59; T378A = 0.36. (G) Substituted cysteine accessibility. a-strep western of cells with strep-tagged Pgm
(CB886, MSMEG_4579, cytoplasmic control), lprG (CB706, Rv1411, periplasmic control) and CwlM1cys (CB457) that
were cysteine-blocked with MTSEA (membrane permeable) or MTSET (membrane impermeable) then alkylated at
Figure 2 continued on next page
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CwlM is phosphorylated by PknB
Mtb has 11 STPKs, which have been shown to phosphorylate many proteins involved in stress and
growth (Molle and Kremer, 2010). To identify the cognate kinase of CwlMTB, we performed phos-
pho-transfer profiling (Baer et al., 2014) using proteins from the pathogen Mtb, which have high
sequence conservation with the Msmeg homologues. We expressed and purified his-CwlMTB and
his-MBP (Maltose Binding Protein) fusions to the Mtb kinase domains (KD) of PknA, B, D, E, F, H, J,
K and L, and measured phosphorylation of his-CwlMTB using Western blotting with an a-phospho-
threonine (a-thr~P) antibody. We found that his-MBP-PknBTB(KD) phosphorylates his-CwlMTB more
rapidly than the other kinases (Figure 3A; Figure 3—figure supplement 1A,B). We used mass spec-
trometry to show that in vitro, his-MBP-PknBTB phosphorylates his-CwlMTB at threonines 382, 384
and 386 (equivalent to T374, 376 and 378 in M. smegmatis, Figure 3—figure supplement 1C).
Thus, the phosphorylation sites in the C-terminal tail of CwlM are conserved in Mtb and Msmeg,
which supports the idea that the strong sequence conservation of the CwlM C-terminal tail across
actinomyecetes (Figure 2B) is functionally relevant.
To test whether PknB affects CwlM phosphorylation in vivo we immunoprecipitated CwlM-FLAG
from an Msmeg strain before and after induction of PknBTB overexpression, and determined the
degree of phosphorylation by comparing reactivity with a-thr~P and a-FLAG antibodies (Figure 3B).
We found that PknBTB overexpression increases CwlM phosphorylation. Thus, PknB is likely the pri-
mary kinase of CwlM. This is consistent with the known essential role of PknB in phosphorylating pro-
teins involved in cell growth and division (Fernandez et al., 2006; Kang, 2005). PknE may also
contribute to CwlM phosphorylation.
Figure 2 continued
unblocked cysteines. Control samples: ( ) = not alkylated or blocked, (+) = alkylated but not blocked. % alkylation
(%alk.) = high band/ total for each sample. The periplasmic localization score = (%alk.MTSEA/% alk.MTSET) and is
indicated below the gel for each protein ± the 95% confidence interval from two biological replicates. Scores < 0.5
are cytoplasmic, near 1 are periplasmic.
DOI: 10.7554/eLife.14590.005
The following figure supplement is available for figure 2:
Figure supplement 1. Growth rates of strains with different cwlM alleles.
DOI: 10.7554/eLife.14590.006
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Figure 3. CwlM is phosphorylated by PknB. (A) a-thr~p western blots of in vitro kinase reactions with the kinase domains of 9 STPKs from Mtb fused to
MBP and his-CwlM from Mtb. Reactions were stopped at 2 min. Longer time points are in Figure 3-figure supplement 1B. (B) a-thr~p and a-FLAG
western blot of lysates from a strain expressing CwlM-FLAG in a PknBTB overexpression (CB418) background. PknBTB was uninduced or induced for 30
min with 100 ng/ml Atc. Ratio = signal of (a-thr~p / a-FLAG)PknB OE / (a-thr~p / a-FLAG)uninduced. Experiments in (A) and (B) were both performed twice,
representative images are shown.
DOI: 10.7554/eLife.14590.007
The following figure supplement is available for figure 3:
Figure supplement 1. Phosphorylation of CwlM.
DOI: 10.7554/eLife.14590.008
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CwlM interacts genetically and physically with MurA, a peptidoglycan
precursor synthesis enzyme
Phosphorylated CwlM appears to be required for normal cellular growth. To identify the molecular
role of CwlM, we screened for spontaneous suppressor mutants that grow rapidly despite carrying
only the growth-restrictive, phospho-ablative cwlM T374A allele. We passaged this strain until we
isolated rapidly growing mutants, which were mapped using whole genome sequencing.
Three of five suppressor strains contained an identical S368P mutation in the gene murA. MurA is
a cytoplasmic enzyme that catalyzes the first dedicated step in PG precursor synthesis: transfer of an
enolpyruvyl group from phosphoenol pyruvate (PEP) onto UDP-N-acetylglucosamine (UDP-GlcNAc)
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Figure 4. CwlM binds to and regulates MurA. (A) Crystal structure of MurA from L. monocytogenes
(Halavaty et al., 2011). Orange: alanine that corresponds to S368 in Msmeg and Mtb MurA; gray: catalytic
cysteine (aspartate in Msmeg and Mtb.). (B) Fitness of cwlM alleles in murA WT (CB737) and S368P (CB762)
backgrounds, assessed by the percentage of colonies in which the WT cwlM allele was replaced by the indicated
allele (WT = pCB277; T374A = pCB255; DCT = pCB557; DcwlM = pCB558). Four biological replicates of each
transformation were performed, and 96–198 colonies were counted for each replicate. The Sidak correction for
multiple comparisons was used to calculate p values using one-way ANOVA. The adjusted p values among the
murA WT strains were calculated compared to cwlM WT: T374A =< 0.0001; DCT =< 0.0001; DcwlM =< 0.0001. The
adjusted p values among the murA S368P strains were calculated compared to cwlM WT: T374A = 0.99;
DCT = 0.006; DcwlM =< 0.0001. (C) a-FLAG and a-strep western blots of immunoprecipitates from the indicated
strain (top three rows, from top: CB300, CB737, CB779) with the indicated antibody-conjugated beads (bottom
two rows). The pulldown was performed twice, a representative image is shown.
DOI: 10.7554/eLife.14590.009
The following figure supplement is available for figure 4:
Figure supplement 1. Growth rates of strains with different cwlM and murA regulatory alleles.
DOI: 10.7554/eLife.14590.010
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(Marquardt et al., 1992). The S368 residue is near the active site, according to an alignment with a
structure of MurA from L. monocytogenes (Halavaty et al., 2011) (Figure 4A).
To confirm that the murA S368P allele suppresses the growth defect of the cwlM T374A allele in
a different genetic background, we performed L5 allele swapping of cwlM in strains encoding either
WT murA or murA S368P. In these strains a WT allele of cwlM is encoded on an L5-integrated con-
struct marked with the nourseothricin resistance gene. We transformed these cells with kanamycin-
marked L5 vectors with alternate alleles of cwlM. Appropriate recombination can be scored by gain
of the kanamycin marker and loss of the nourseothricin marker. We found that the cwlM T374A allele
and a deletion of the C-terminal tail are poorly tolerated in a WT murA background, but can be
recovered at near WT levels in a murA S368P background. The entire cwlM gene cannot be deleted
in either background (Figure 4B). The strain carrying murA S368P alone grows at the same rate as
WT, the strain with both mutant alleles has a slight growth defect, but grows much more rapidly
than the strain with cwlM T374A and WT murA (Figure 4—figure supplement 1).
These results confirm that cwlM and murA interact genetically. To test whether the proteins phys-
ically interact, we immunoprecipitated proteins from a strain containing cwlM-FLAG and murA-strep
with both a-FLAG and a-strep beads. We found that CwlM-FLAG could be precipitated with a-strep
beads, but only in the presence of MurA-strep, and vice versa (Figure 4C). Thus, there is a genetic
link between cwlM and murA, and the two proteins interact.
CwlM ~P stimulates the enzymatic activity of MurA
We hypothesized that CwlM~P activates MurA and that MurA is less active when CwlM is less phos-
phorylated, resulting in the inhibition of cell growth seen in the cwlM T374A mutant. This hypothesis
is based on the observation that the phospho-ablated cwlM T374A is suppressed by murA S368P
(Figure 4B), which is likely to be a gain-of-function mutation because murA is an essential gene
(Griffin et al., 2011) and the mutation does not affect growth rate (Figure 4—figure supplement
1). To test this model we expressed and purified his-MurATB and his-CwlMTB from E. coli and per-
formed kinetic assays of his-MurATB activity by measuring the accumulation of the MurA product,
enolpyruvyl-UDP-N-acetylglucosamine (EP-UDP-GlcNAc), by HPLC (Figure 5A). We compared the
activity of his-MurATB alone and in the presence of his-CwlMTB and his-CwlMTB~P phosphorylated on
T382, 384 and 386 by his-MBP-PknBTB (Figure 3—figure supplement 1B). We found that the reac-
tion rate of his-MurATB is 20–40 times faster in the presence of equimolar his-CwlMTB~P (Figure 5)
than it is alone or with unphosphorylated his-CwlMTB. We found that nearly all his-CwlMTB incubated
with his-MBP-PknBTB is phosphorylated on at least one site (Figure 5—figure supplement 1F); how-
ever, because there are three phosphorylation sites, it is likely a heterogeneous mixture. his-CwlMTB
with different degrees of phosphorylation may stimulate MurA activity differently, thus the rates in
Figure 5D represent a population average of the rates from his-CwlMTB in different states.
his-CwlMTB with phosphoablative mutations does not appreciably stimulate his-MurATB activity
after incubation with his-MBP-PknBTB and ATP (Figure 5E). his-CwlMTB alone cannot synthesize EP-
UDP-GlcNAc; MurA is not thought to be phosphorylated (Prisic et al., 2010) and his-MBP-PknBTB
cannot stimulate MurA activity in the absence of his-CwlMTB (Figure 5E). We measured the stoichi-
ometry of the CwlM:MurA reaction and found that his-MurATB is maximally activated in a reaction
with a 2-fold molar excess of fully phosphorylated his-CwlMTB~P (Figure 5—figure supplement 1E,
F). Thus, CwlM~P activates MurA to initiate PG synthesis. These data with Mtb proteins confirm our
model based on the genetic data in Msmeg, and show that CwlMTB~P is a direct activator of
MurATB.
MurA activity is downregulated in the transition to starvation
MurA from other species have been studied in vitro and shown to have much more rapid kinetics
and lower Km values than isolated MurATB (Figure 5B,C; Figure 5—figure supplement 1;
Supplementary file 1D [Xu et al., 2014]). Why would an essential housekeeping enzyme evolve to
be almost inactive by default and require activation by another factor?
We hypothesized that this MurA regulatory pathway could exist to restrict PG synthesis in stresses
such as nutrient starvation, because cell length decreases in starvation (Figure 6—figure
supplement 1A) and when CwlM is deactivated (Figures 1D, E, 2E). To test this, we immunoprecipi-
tated CwlM-FLAG from Msmeg cultures in log phase and starvation and measured the degree of
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Figure 5. CwlM~P activates MurA in vitro. (A) An HPLC trace from the MurATB kinetic assays, with substrate UDP-
GlcNAc and product EP-UDP-GlcNAc indicated. Assays were done on his-MurATB alone, his-MurATB with
equimolar his-CwlMTB~P in an active kinase reaction (+ATP) with his-MBP-PknBTB(KD) (a his-Maltose binding
protein fusion to the kinase domain (KD) of PknB from Mtb), or his-MurATB with his-CwlMTB in an inactive kinase
reaction (-ATP) with his-MBP-PknBTB(KD). (B) Rate of MurA activity vs. the concentration of phosphoenol pyruvate
(PEP). Lines are the fit to the Michaelis Menten model. (C) Rate of MurA activity vs. the concentration of UDP-
GlcNac for each MurA reaction condition. MurA and MurA+CwlM did not follow Michaelis Menten kinetics, (lines
only connect the dots), for MurA+CwlM~P the line is the Michaelis Menten fit. The assays shown in (B) and (C)
were done twice with two separate preps of his-MurATB and his-CwlMTB. Data from one replicate is shown here,
full data in Figure 5 - figure supplement 1A–D. (D) Michaelis Menten kinetic constants from experiments in (B)
and (C). Constants are the average ± the 95% confidence interval from the two replicates. (E) Amount of EP-UDP-
GlcNAc produced after 30 min at 37˚C in reactions with 2 mM PEP and 15 mM UDP-GlcNAc and his-MurATB at 20
mg/ml; his-CwlMTB at 20.2 mg/ml; his-MBP-PknBTB(KD) at 2 mg/ml and ATP at 1 mM where indicated. his-CwlMTB
was incubated with his-MBP-PknBTB and ATP for 1 hr at RT before initiating the MurA reaction. T382A indicates
that the singly-phosphoablative mutant protein his-CwlMTB T382A was used. 3T->A indicates that the triply-
phosphoablative mutant protein his-CwlMTB T382A T384A T386A was used. Experiment was performed 2 times.
DOI: 10.7554/eLife.14590.011
The following figure supplement is available for figure 5:
Figure supplement 1. MurA enzyme kinetics.
DOI: 10.7554/eLife.14590.012
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phosphorylation. We found that CwlM phosphorylation is quickly reduced upon starvation in PBS
(Figure 6A).
These results, together with the biochemical data and the observation that MurA protein levels
do not change substantially in starvation (Figure 6—figure supplement 1B), suggest that phosphor-
ylation of CwlM converts MurA to an ’on’ state and that during starvation, decreased CwlM phos-
phorylation blocks further PG synthesis - because MurA alone or in the presence of
unphosphorylated CwlM has very low activity (Figure 5). To assess the importance of this post-trans-
lational regulation of MurA on mycobacterial physiology, we further studied the murA S368P
mutant.
The genetic data predict that murA S368P is active without CwlM phosphorylation. To test this,
we expressed and purified his-MurAMS WT and S368P and measured their activity alone and with
his-CwlMTB and his-CwlMTB~P. We found that his-MurAMSS368P is more active than the WT protein
in all conditions by about 2-fold (Figure 6B). This suggests that the mutant enzyme should produce
more PG precursors than the WT strain, even in starvation. We assessed PG activity using a fluores-
cently labeled D-alanine analogue TAMRA-D-alanine (TADA), which is thought to be incorporated
primarily into metabolically active PG (Kuru et al., 2012). We observed increased fluorescence in
the strain carrying murA S368P as compared to the WT allele during the first 12 hr of PBS starvation,
but, by 24 hr, the staining was equivalent between the strains (Figure 6C). Controls show that TADA
staining is specific to the cell wall (Figure 6—figure supplement 1C,D). We interpret this to mean
that post-translational regulation of MurA is important to control PG metabolism in logarithmic
phase growth and during the transition to starvation, but that after prolonged starvation other regu-
latory mechanisms predominate to control PG metabolism. The abrupt cessation of growth (Fig-
ure 6—figure supplement 1E) and decreased CwlM phosphorylation (Figure 6A) imply that
incorporation of new PG decreases upon starvation in the WT strain; however, TADA staining
remains constant (Figure 6C). This suggests that TADA staining in these conditions may be due
more to exchange of D-alanine in the periplasm by Ldts (Cava et al., 2011) than to incorporation of
new, labeled PG transported from the cytoplasm. Regardless, the over-activation of MurA clearly
alters PG metabolism during the transition to starvation.
Regulation of PG biosynthesis contributes to antibiotic tolerance
Decreased synthesis of PG precursors and cell wall metabolism is an important adaptation to stress:
subverting this regulation should be disadvantageous. Many models suggest that decreased metab-
olism contributes to Mtb’s antibiotic tolerance during treatment. This is based on the observation
that many antibiotics are less effective during starvation and stationary phase in Mtb (Betts et al.,
2002; Herbert et al., 1996; Wallis et al., 1999; Xie et al., 2005) and other bacteria, likely because
the activity of drug targets is reduced, or because permeability is decreased (Kester and Fortune,
2014; Sarathy et al., 2013). We hypothesized that continued synthesis of PG during the transition
to starvation could reduce antibiotic tolerance. To test this, we subjected cells to PBS starvation and
measured antibiotic sensitivity in strains with murA WT and S368P alleles. We found a 3–100 fold
increase in killing of the strain carrying the murA S368P allele when the strains were treated with iso-
niazid, meropenem or rifampin at the initiation of starvation (Figure 6D). The mutant also had a sig-
nificant antibiotic tolerance defect in nutrient rich media, but not when the antibiotics were added
late in starvation (Figure 6—figure supplement 1F,G), after the period in which post-translational
regulation of MurA affects PG metabolism (Figure 6C). We conclude that the PknB-CwlM-MurA sig-
naling cascade functions to quickly turn off PG synthesis during nutrient restriction (Figure 7), and
that this regulation contributes to antibiotic tolerance during growth and under changing conditions.
CwlM protein evolution was driven by cytoplasmic localization
CwlM’s function could not have been predicted from available knowledge about the function of its
conserved domains. Based on domain structure, it seems likely that an ancestral cwlM homologue
was a periplasmic enzyme involved in PG hydrolysis. How could such a protein evolve into a cyto-
plasmic, phosphorylation-responsive regulator of PG biosynthesis? To address this, we searched for
cwlM homologues that retained both PG binding domains and the PG amidase domain in the same
arrangement as is seen in the mycobacterial proteins (Figure 7A), and found that almost all
such homologues were found in members of the phylum Actinobacteria. We chose representatives
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Figure 6. MurA is downregulated in starvation, contributing to drug tolerance. (A) a-thr~P western blot showing the level of CwlM phosphorylation in
the cwlM::FLAG strain (CB100) in log. phase and upon starvation in PBS. Ratio = signal of (a-thr~p / a-FLAG)starvation / (a-thr~p / a-FLAG)log phase(B)
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and either no or equimolar his-CwlMTB or his-CwlMTB~P. (C) Fluorescent intensity of WT (CB779) and murA S368P (CB782) cells pulse stained with
TADA in log. phase HdB culture (t = 0) and at time points after initiation of starvation in PBS+tween 80, as measured by flow cytometry. The median
fluorescence for 10K+ cells is shown. On the right are representative images of cells from the t = 0 (log. phase) and t = 24 (starved) time points. Phase
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student’s t test. Isoniazid = 0.0087; meropenem = 0.0082; rifampin = 0.0067.
DOI: 10.7554/eLife.14590.013
The following figure supplement is available for figure 6:
Figure supplement 1. Phenotypes of murA S368P.
DOI: 10.7554/eLife.14590.014
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from each family and searched for the presence of a secretion signal, the conservation of the four
Zn2+-coordinating residues, and the presence of a PTG or TGT phosphorylation motif in the C-
-terminal tail. We constructed a phylogenetic tree based on 16S rRNA sequence of the species that
have cwlM homologues and some representative species from families that do not, and mapped
onto it the conservation of the three cwlM features (Figure 7B). We found that all actinobacterial
cwlM homologues lack secretion signals. Potential phosphorylation motifs are conserved in most
clades, irrespective of whether or not they conserve the canonical Zn2+-coordinating residues. These
data imply that both CwlM cytoplasmic localization and, possibly, regulation by phosphorylation
were present in an ancestor of the Actinobacteria.
Discussion
Here we describe a regulatory system in which the essential STPK PknB phosphorylates the cyto-
plasmic PG amidase homologue CwlM, which then directly activates the catalytic activity of MurA,
the first enzyme in the pathway of PG biosynthesis. During starvation, phosphorylation of CwlM is
rapidly reduced, which leads to MurA deactivation and helps control PG metabolism at the cell wall.
When this regulatory pathway is subverted by over-activation of MurA in Msmeg, cells become
more sensitive to antibiotics.
CwlM has a critical role in signal transduction
CwlM is essential in M. smegmatis, but its amidase activity does not appear to be essential (Fig-
ure 1). However, a strain with a phospho-ablative mutation, cwlM T374A, exhibits defects in elonga-
tion (Figure 2) and reduced viability in a manner reminiscent of CwlM depletion. The cwlM T374A
mutant strain has such low viability that it could not be constructed except in a genetic background
that ‘forced’ the L5 allele swap by repressing transcription of cwlM in transformants that maintained
a wild type copy of the cwlM allele (See Figure 2 and 4B ; Figure 4—figure supplement 1;
Supplementary file 1 ). We show that the murA S368P mutation restores normal growth of the
cwlM T374A mutant (Figure 4B; Figure 4—figure supplement 1) which implies that phosphoryla-
tion of CwlM activates MurA. The short cells seen in the CwlM depletion and the cwlM T374A
mutant look similar to Msmeg cells with a temperature sensitive MurA mutation, which are also short
and have compromised cell walls (Xu et al., 2014).
The loss of viability in the cwlM mutants and temperature sensitive murA strain (Xu et al., 2014)
could be due to uncoordinated synthesis of the various layers of the cell wall: peptidoglycan biosyn-
thesis is downregulated but other cell wall biosynthetic and metabolic processes may remain active,
leading to a cell wall with poor structural integrity. This differs from wild-type regulation during star-
vation, when PG regulation is likely accompanied by regulation of other cell wall layers. In fact, PknB,
the kinase likely responsible for physiologic CwlM phosphorylation, has been implicated in the regu-
lation of many cell wall processes (Khan et al., 2010; Molle et al., 2006; Parikh et al., 2009;
Vilche`ze et al., 2014), and probably helps to coordinate regulation of the various cell wall layers.
The enzymatic activity of other PknB substrates changes less upon phosphorylation (Khan et al.,
2010; Molle et al., 2006; Parikh et al., 2009) than the ~30-fold activation of MurA by CwlM~P. It is
possible that PknB may regulate other factors like it does MurA – indirectly through intermediary
substrates.
CwlM may integrate information from multiple signals
Both PknB and PknE can phosphorylate CwlM in vitro. Because PknB acts more rapidly (Figure 3A)
it is likely to be the primary kinase of CwlM. In nutrient replete conditions PknB apparently activates
Figure 7 continued
homologues, and are representatives of larger clades. All homologues lack a predicted secretion signal. The conservation of an intact or degenerate
amidase active site and the presence of a PTG or TGT phosphorylation motif are indicated by color. (C) Model for the regulation of MurA. In nutrient
rich conditions PknB phosphorylates CwlM, which can then promote the activity of MurA, resulting in increased flux through the PG biosynthetic
pathway (indicated by the series of arrows) and promoting cell growth. In starvation, PknB is poorly expressed, CwlM is not phosphorylated, and MurA
is therefore not activated, resulting in reduced production of PG precursors, which helps to halt cell growth.
DOI: 10.7554/eLife.14590.015
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MurA by phosphorylating CwlM. How is the phosphorylation cascade regulated in starvation? PknB
can be transcriptionally (Kang, 2005) and post-translationally regulated (Baer et al., 2014). How-
ever, the rapid decrease in CwlM phosphorylation (Figure 6B) implies that there is a CwlM
phosphatase.
CwlM is a cytoplasmic PG hydrolase homologue. While most PG hydrolases are in the periplasm,
there are cytoplasmic PG hydrolases that are involved in enzymatic processing of recycled anhydro-
muropeptides (Jacobs et al., 1994; 1995; Park and Uehara, 2008). The level of cytoplasmic anhy-
dro-muropeptides can be a signal reporting on environmental conditions (Jacobs et al., 1994;
1995; Park and Uehara, 2008;Nu´n˜ez et al., 2000). If CwlM is involved in processing or detection of
anhydro-muropeptides, it could integrate information about their levels into its regulation of PG pre-
cursor synthesis.
Regulation of MurA toggles PG biosynthesis in response to prevailing
conditions
Because MurA is the first committed step in PG biosynthesis, its regulation is an efficient point at
which to regulate the pathway. This is certainly true in other species. MurA from E. coli is subject to
feedback regulation (Mizyed et al., 2005), and many Gram positive species have two MurA homo-
logues which are differentially regulated (Blake et al., 2009; Kock et al., 2003). Mycobacteria have
only one MurA homologue, but the regulation by CwlM allows it to quickly and precisely adjust its
enzymatic activity for different conditions without being proteolyzed and requiring re-synthesis (Fig-
ure 6—figure supplement 1B). Our data imply that the post-translational regulation of MurA is
important for cell wall regulation at early time points during stress (Figure 6C). It is likely that tran-
scriptional (Dahl et al., 2003) and proteolytic (Festa et al., 2010) systems downregulate cell wall
enzymes after prolonged starvation or stress.
The Kcat values we measured for MurA alone by varying PEP concentration are comparable to the
values measured previously (Xu et al., 2014), and the Kcat of MurA with CwlM~P was ~30 times
higher. We and others have measured high Km values for UDP-GlcNAc (Figure 5D;
Supplementary file 1D; Figure 5—figure supplement 1 and [Xu et al., 2014]), which surely exceed
the concentrations in the cell; thus, there are probably other factors that regulate MurA and either
reduce the Km or increase the local concentration of UDP-GlcNAc.
A regulatory system for PG biosynthesis contributes to drug tolerance
One of the major limitations in treating tuberculosis is the extended course of therapy required in
part because of phenotypic drug tolerance, which is thought to be a result of decreased metabolic
activity of drug targets, and decreased permeability. Subverting signals that downregulate metabo-
lism in these bacteria could re-sensitize them to antibiotics. We find that this is true during the transi-
tion to starvation in Msmeg grown in culture. A strain carrying the murA S368P allele is unable to
properly downregulate PG metabolism, and is more sensitive to several antibiotics early in starvation
(Figure 6D). Because this increased killing was seen in the presence of isoniazid and meropenem,
which target the cell wall, as well as rifampin, which does not, we think that the increased cell wall
metabolism results in higher permeability, and that the increased killing is due to greater drug
uptake (Sarathy et al., 2013).
Our data imply that MurA inhibitors (De Smet et al., 1999) might contribute to death of actively
growing mycobacteria early in treatment, but that they could also contribute to drug tolerance of
non-growing bacteria, which are likely to dominate later in treatment. While our experiments were
conducted in vitro with Mtb proteins, the conservation of these proteins among mycobacteria sug-
gest that the PknB-CwlM-MurA regulatory pathway is conserved, although it is likely that different
stresses activate MurA regulation in Mtb compared to Msmeg. Treatments that interfere with the
regulation of the mycobacterial cell wall during infection could shorten treatment times and improve
patient outcomes.
The evolution of CwlM function
Biological complexity is predicated on the diversity of protein function. How do novel protein func-
tions evolve? One hypothesis is that compartmental re-targeting of duplicated genes is critical to
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the evolution of complexity in eukaryotic cells (Bright et al., 2010; Gabaldo´n and Pittis, 2015). It is
less clear that this same mechanism would drive the evolution of complexity in bacteria.
Here, though, we find a bacterial example of evolutionary repurposing through new compartmen-
talization. Because CwlM consists of three functional domains, all of which are predicted to function
in the periplasm, we assume that an ancestral homologue was periplasmic. However, all of the avail-
able cwlM homologues lack a predicted secretion signal. These homologues are found throughout
the Actinobacteria, implying that a cwlM ancestral homologue was re-targeted to the cytoplasm
before the actinobacterial phylum split off from its relatives. The conservation of the putative phos-
phorylation motif implies that cwlM homologues in most Actinobacteria have a role in signal trans-
duction. Because periplasmic proteins are not known to be phosphorylated, this signaling role likely
evolved after CwlM was re-targeted to the cytoplasm.
CwlM provides cells with an additional layer of regulation of PG synthesis. MurA from Gram nega-
tive (Dai et al., 2002; Krekel et al., 2000) and positive species (Blake et al., 2009; Du et al., 2000)
are regulated transcriptionally and by proteolysis (Blake et al., 2009; Kock et al., 2003). In myco-
bacteria, enzymes in PG biosynthesis are regulated transcriptionally (Dahl et al., 2003) and proteo-
lytically (Festa et al., 2010), in addition to the regulation of MurA through phosphorylation of CwlM
described here. Thus, compartmental re-targeting of the ancestral CwlM protein has allowed for the
evolution of a complex regulatory system by which mycobacteria, and possibly related Actinobacte-
ria, control synthesis of PG precursors in response to environmental conditions.
Materials and methods
Bacterial strains and culture conditions
Mycobacterium smegmatis mc2155 was grown in 7H9 salts (Becton-Dickinson, Franklin Lakes, NJ)
supplemented with: 5 g/L albumin, 2 g/L dextrose, 0.85 g/L NaCl, 0.003 g/L catalase, 0.2% glycerol
and 0.05% Tween80, or plated on LB agar. Hartmans-de Bont (HdB) media was made as described
(Hartmans and De Bont, 1992) with 0.05% tween80, HdB-C was made without glycerol. E. coli
DH5a was used for cloning and E. coli BL21 codon plus or ArcticExpress DE3 RP were used for pro-
tein expression. Antibiotic concentrations for M. smegmatis were: 25 mg/ml kanamycin, 50 mg/ml
hygromycin, 20 mg/ml zeocin and 20 mg/ml nourseothricin. Antibiotic concentrations of E. coli were:
50 mg/ml kanamycin, 100 mg/ml hygromycin, 25 mg/ml zeocin, 40 mg/ml nourseothricin, 20 mg/ml
chloramphenicol and 140 mg/ml ampicillin. All strains were grown at 37˚C.
Strain construction
Knockouts of cwlM and murA were made by first complementing the genes at the phage integrase
sites L5 (Lewis and Hatfull, 2003) and Tweety (Pham et al., 2007), and then using recombineering
to delete the endogenous copy. ~500 base pair regions upstream and downstream of the gene
were amplified by PCR and PCR stitched to either side of a zeocin resistance cassette. The assem-
bled PCR fragment was transformed into Msmeg strains expressing the RecET proteins. The result-
ing colonies were screened for deletion of the gene (van Kessel and Hatfull, 2008). To make
CB737, the zeocin resistance cassette in the deletions was removed by the Cre recombinase
between each subsequent deletion. After complementing murA at the Tweety site and deleting the
endogenous murA, we found that there was still another copy of murA in its native genomic context.
This led to our discovery of an IS1096-mediated (Wang et al., 2008) genomic duplication which
comprises MSMEG_4928–4944 (murA is MSMEG_4932) and is present in most of our Msmeg strains.
We deleted the second copy of murA by removing the zeocin cassette in the first deletion via Cre
recombinase, and using the same knockout construct to delete the second copy.
The cwlM::FLAG (CB100) strain was also made by recombineering. ~500 base pair regions
upstream and downstream of the stop codon of cwlM were amplified and PCR stitched to a zeocin
cassette, which was transformed as described above.
Different alleles of cwlM were attained by swapping the nourseothricin resistance-marked vector
with WT cwlM for a kanamycin resistance-marked mutant allele, as described (Pashley and Parish,
2003). We also exchanged the murA allele at the Tweety integrase site in the same way as is done
at the L5 site. Full strain details in Supplementary file 1A–C.
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Cell staining, microscopy and image analysis
For polar growth quantification, cells were stained with AlexaFluor488 carboxylic acid succinimidyl
ester as described (Aldridge et al., 2012), resuspended in 7H9 media, shook at 37˚C for 3 hr, immo-
bilized on agarose pads and imaged in phase and GFP channels with a Nikon TE-200E microscope
with a 60X objective and Orca-II CCD camera (Hamamatsu, Japan). The Ptet::cwlM strain was grown
uninduced for 9 hr before staining. Images were analyzed in ImageJ (NIH). The length of the longer
unstained pole and the total cell length was measured manually for each cell.
D-alanine staining and flow cytometry
For the TADA experiment, cells were grown in HdB. 1 ml of 10 mM TADA (synthesized according to
[Kuru et al., 2014]) was added to 1 mL of culture and incubated for 5 min before washing with PBS
+tween80 and fixing for 10 min with 1% paraformaldehyde. The rest of the culture was pelleted,
resuspended and cultured in PBS+tween80, and aliquots were stained the same way at 1, 4, 8, 12
and 24 hr after resuspension. Controls were performed on cells growing in HdB: cells were either
fixed first and then stained, or fixed and not stained at all. The samples were filtered through a 10
mm filter and analyzed by flow cytometry (MACSQuant VYB Excitation: 561 nm; Emission filter: 615/
20). The settings for FSC, SSC, and cell density were adjusted to sample single cells. Three biological
replicates were used for each strain and time point, and the median fluorescence for 50,000 cells
from each replicate was calculated and averaged.
D-alanine staining and cell fractionation
75 mL replicate cultures of murA WT and murA S368P growing in HdB were stained for 15 min at
37˚C with 10 mM TADA. Cells were pelleted and washed twice with PBS+tween80, resuspended in
water and boiled for 1 hr, and spun at 100 K rpm for 20 min. The supernatants were collected, and
the pellets resuspended in PBS+2.5% SDS, boiled for 1 hr, nutated O/N at 37˚C, and spun at 21 K
rpm for 15 min. The supernatants were collected and the pellets were washed twice with PBS. The
fluorescence of each sample was measured with a Spectra284 plate reader (Excitation: 541, Emis-
sion: 568). The water and SDS extracted supernatants were measured undiluted. The cell wall pellet
suspension was diluted 120 fold, which was required for measurements to be within the linear range.
The fluorescence values of the cell wall fractions measured by the plate reader were therefore multi-
plied by 120.
Protein purification and phospho-transfer profiling
N-terminally his-MBP-tagged kinase domains of the nine canonical serine-threonine protein kinases
from Mtb were expressed and purified as described (Kieser et al., 2015). His-CwlM was expressed
with 1 mM IPTG at 14˚ for 40 hr in ArcticExpress DE3 RP (Agilent, Lexington, MA). Cells were resus-
pended and French-pressed in Ni Wash Buffer (50 mM NaHPO4 pH 8.0, 300 mM NaCl, 20 mM imid-
azole), and supernatants were poured over TALON affinity resin (Clontech, Mountain View, CA).
Bound proteins were washed and eluted with Ni Wash Buffer + 200 mM imidazole. Soluble proteins
were separated from aggregates on a Superdex S200 gel filtration column (GE Healthcare,
Westborough, MA) in 20 mM Tris pH 7.5, 150 mM NaCl, 1 mM DTT. Soluble proteins were concen-
trated and stored in 50 mM NaPO4 pH 7.5, 150 mM NaCl, 20% glycerol, 2 mM DTT, 1 mM PMSF.
Kinase reactions, a-phospho-threonine western blots and mass spectrometry were performed as
described (Kieser et al., 2015).
Growth rate determination
Growth curves of M. smegmatis strains were done in triplicate, the OD600 of each culture was mea-
sured every 30 min in a Bioscreen growth curve machine (Growth Curves USA, Piscataway, NJ).
Conservation of C-terminal tail
To determine the conserved features of the C-terminus of CwlM, the entire CwlM protein sequence
was BLASTed against the genus Mycobacteria, and the C-terminal tail from the 34 most similar
mycobacterial, and 98 most similar Actinomycetes CwlM proteins was analyzed using Weblogo
(Crooks et al., 2004).
Boutte et al. eLife 2016;5:e14590. DOI: 10.7554/eLife.14590 16 of 22
Research article Biochemistry Microbiology and Infectious Disease
2D gels, SDS-PAGE and western blots
For 2D gels and phosphothreonine quantification of CwlM, CwlM-FLAG was immunoprecipitated by
bead beating cells in 50 mM Tris pH7.5, 300 mM NaCl with Protease Inhibitor Cocktail
(Roche, Switzerland). a-FLAG M2 Magnetic Beads (Sigma Aldrich, Natick, MA) were added to super-
natants and washed with 50 mM NaHPO4, 300 mM NaCl. CwlM was eluted from the beads with 0.5
mg/ml FLAG peptide in TBS. Samples were separated in 2D using the ReadyPrep 2D Starter Kit (Bio-
Rad, Hercules, CA), according to the manufacturer’s protocols. SDS-PAGE was done with 4–12%
NuPAGE Bis Tris precast gels (Life Technologies, Beverley, MA). Mouse a-FLAG (Sigma Aldrich) was
used at 1:10,000 in TTBS, Rabbit a-strep (Genscript, China) and Rabbit a-phosphothreonine (Cell
Signaling Technology, Danvers, MA) were used at 1:1000 in TTBS + 0.5% BSA.
Substituted cysteine accessibility
Cultures of the L5::cwlM1cys-strep, L5::lprG-strepC and L5::pgm-strepC strains were grown to late
log phase, washed twice and resuspended in PBS + 0.25% tween80, split and treated with 0 or 0.6
mg/ml of MTSEA and MTSET (Biotium, Hayward, CA) for 20 min at RT. Blocking was quenched with
cysteine at 50 mM; cells washed in PBS + 0.05% tween80, and resuspended in PEGylation buffer
(600 mM Tris pH 7.4, 10 M Urea, 2% SDS, 1 mM EDTA), heated at 85˚ for 20 min and spun. 5.6 mg
of MalPEG5K (Sigma Aldrich) was added to all the supernatants except (-) controls and incubated at
37˚ for 2 hr. Proteins were TCA precipitated and visualized by a-strep western blot.
CwlM allele survivability
To confirm the suppression of the cwlM T374A allele by the murA S368P allele, the L5::cwlM(nuoR)
tw::murA (CB737) and L5::cwlM(nuoR) tw::murA S368P (CB762) strains were transformed with
pCB255, pCB277, pCB557 and pCB558 and plated on kanamycin. For each of 3–4 transformations,
kanamycin and nourseothricin resistance was assessed for 96-192 colonies.
CwlM-MurA co-immunoprecipitation
Cultures of CB779, CB737 and CB300 were grown to mid-log phase, washed, resuspended in PBS +
0.25% paraformaldehyde, incubated at 37˚ for 2 hr, quenched with 40 mM glycine, washed and
lysed by French press. a-strep was conjugated to Protein G dynabeads (Novex, Cambridge, MA)
which were added to the CB300 and the CB779 lysate. a-FLAG beads were added to the rest of the
CB779 lysate and the CB737 lysate. Pull-downs were done according to the manufacturers proto-
cols, and proteins visualized by western blot.
MurA kinetic assays
his-MurA was purified like his-CwlM. Reactions with 20 mg/ml of his-MurA, equimolar his-CwlM in
the kinase reaction, and varying concentrations of substrate were run as in (Brown et al., 1994).
MurA kinetic assays were done with MurATB alone in MurA reaction buffer (50 mM Tris pH 8.0,
2 mM Kcl, 2 mM DTT) or with equimolar CwlMTB in a kinase reaction with His-MBP-PknBKD. The
kinase reactions contained: 202 mg/ml CwlMTB, 50 mg/ml His-MBP-PknBKD, 2 mM ATP, 2 mM MnCl2
and were brought up to 100 ml with Buffer C (20 mM Tris pH 7.5, 150 mM NaCl, 1 mM DTT). Inactive
kinase reactions had extra buffer instead of ATP. Kinase reactions were run for 1 hr at room temper-
ature before being added to the MurA reactions. MurA reactions contained: 20 mg/ml MurA and
20.2 mg/ml CwlM in the kinase reaction (1/10 of MurA reaction was CwlM kinase reaction, or buffer
for MurA alone kinetics). In MurA reactions with varying PEP, UDP-GlcNac was at 10 mM and PEP
concentrations were: 25, 100, 250, 500 and 1000 mM; these reactions were started with the addition
of UDP-GlcNAc. In MurA reaction with varying UDP-GlcNac, PEP was at 2 mM and UDP GlcNac con-
centrations were: 0.5, 1, 3, 5, 8, 10 and 15 mM; these reactions were started with the addition of
PEP. 2, 5 and 8 min time points were taken for the MurA + CwlM~P reaction; 5, 15 and 25 min time
points were taken for the MurA and MurA +CwlM reactions. At the indicated time point, a 25 ml ali-
quot of the reaction was removed and quenched in an equal volume of 400 mM KOH. The quenched
reactions were spun in Microcon 10 K devices (EMD Millipore, Billerica, MA) and chilled until being
injected into the Agilent HPLC. HPLC separation was performed on a MonoQ 5/50 GL anion
exchange column (GE Healthcare) with the following protocol: 0.6 ml/min; 2 min of 20 mM tetrae-
thylammonium bicarbonate pH 8.0, an 18 min gradient from 20–500 mM tetraethylammonium
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bicarbonate pH 8.0, 5 min of 500 mM tetraethylammonium bicarbonate pH 8.0, 5 min of 20 mM tet-
raethylammonium bicarbonate pH 8.0. The area under the A254 curve peak corresponding to EP-
UDP-GlcNAc was integrated using Agilent ChemStation software.
Because EP-UDP-GlcNac is not commercially available, we were not able to perform a standard
curve of product concentrations to determine the relationship between peak area and product con-
centration. Instead, we measured the peak area of a range of UDP-GlcNac concentrations, and
found that a peak area of 11.73 in the A254 curve was consistently equivalent to 1 uM of UDP-
GlcNac. Because UDP-GlcNac and EP-UDP-GlcNac differ only in one enol-pyruvyl group, we rea-
soned that the relationship between A254 peak area and concentration should be comparable
between these two molecules. We therefore divided the values for peak area for each EP-UDP-
GlcNac peak by 11.73 to calculate the approximate mM concentration of EP-UDP-GlcNac. These val-
ues were plotted vs. time for each substrate concentration and the rate of product produced vs.
time was calculated based on the linear portions of the curves. The resulting rates were plotted
against substrate concentration in the curves shown in Figure 5 and Figure 5—figure supplement
1. The peak that corresponds to EP-UDP-GlcNAc was identified because it appeared only when
MurA and UDP-GlcNAc were incubated with PEP. The data were fitted to the Michaelis Menten for-
mula using GraphPad Prism.
Antibiotic kill curves
Biological replicates of CB779 (murA) and CB782 (murA S368P) were grown in 7H9, transferred to
PBS+tween80, diluted to OD = 0.05, treated with 100 mg/ml isoniazid, 50 mg/ml rifampin or 20 mg/
ml meropenem, and rolled at 37˚ during the CFU measurement period. For the unstarved kill curves
(Figure 6—figure supplement 1C), log. phase cultures in 7H9 were diluted to OD = 0.05 in 7H9
and treated with 50 mg/ml isoniazid, 20 mg/ml rifampin or 5 mg/ml meropenem. For Figure 6—figure
supplement 1D, the log. phase 7H9 cultures were transferred to PBS+tween80, diluted to
OD = 0.05 and rolled at 37˚ for 18 hr before 100 mg/ml isoniazid, 50 mg/ml rifampin or 20 mg/ml
meropenem was added.
CwlM feature conservation analysis
A CDART search was used to identify cwlM homologues with the same domain structure. All but 3
of these were in the Actinobacteria, the remaining 3 are in the Firmicutes. The ~700 CDART hits
were separated by family, and a phylogenetic tree was made of each family. Between 3 and 16
homologues, representing the breadth of the phylogenetic distribution, were chosen from each fam-
ily, leaving 97 homologues. The secretion signal identification programs Phobius (Kall et al., 2007)
and PRED-TAT (Bagos et al., 2010) were used to assess the N-terminus of each homologue for the
presence of a Sec or Tat secretion signal. The COBALT tool on NCBI was used to align the amidase
domain of each homologue to active amidase domains of the same family; the conservation of the
four Zn+2-coordinating residues was assessed for each. Each homologue was then searched for the
presence of either PTG or TGT motifs in the C-terminal region after the amidase domain. 16S rRNA
sequences were collected from the species with the 97 CwlM homologues, and from representative
species from across the clade of Actinobacteria (Lang et al., 2013) that do not have CwlM homo-
logues. The 16S sequences were aligned with Clustal Omega and a distance-matrix tree was con-
structed and visualized in ITOL (Letunic and Bork, 2011).
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